文献速递慢性静脉疾病静脉血栓栓塞

使用Vici静脉支架对慢性髂静脉闭塞行再通术后两年结局

Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent®.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-08-20

这项回顾性单中心研究评估了Vici静脉支架治疗慢性髂股静脉闭塞的两年结局,共纳入88例患者(101条肢体),于2014年3月至2016年10月置入支架。结果显示一年一期、辅助一期和二期通畅率分别为59%、78%和87%,两年分别为51%、73%和82%;24个月时53条肢体中37条(70%)Villalta评分较基线改善超过30%。结论认为该支架与良好的二期通畅率和持久的症状缓解相关。

要点

  • 两年二期通畅率为82%,一年为87%。
  • 43%的肢体在随访期间接受了再干预,中位再干预时间为32天。
  • 24个月时70%可评估肢体Villalta评分改善超过30%。

核心结论

  • Vici静脉支架与慢性血栓后闭塞患者良好的二期通畅率以及持久且显著的症状缓解相关,无论支架是否延伸至腹股沟韧带下方。

研究设计与样本

  • 回顾性单中心研究,纳入88例患者(101条肢体),均为经静脉造影证实的髂股静脉闭塞且急性深静脉血栓形成后至少12个月、Villalta评分≥5分的血栓后综合征患者,于2014年3月至2016年10月置入Vici静脉支架。

主要发现

  • 中位影像随访21个月(范围0-41个月),一年一期、辅助一期和二期通畅率分别为59%、78%和87%,两年分别为51%、73%和82%。
  • 43条肢体(43%)在随访期间接受再干预(溶栓、静脉成形术和/或支架置入),中位再干预时间为32天(范围0-520天)。
  • 24个月时,53条有Villalta评估的肢体中37条(70%)显示临床显著改善(较基线评分降低超过30%)。
  • 支架置入后6、12和24个月临床随访时Villalta评分均显著低于支架置入前(各时间点p均<0.001)。
  • 亚组分析中,支架终止于腹股沟韧带上方和下方的肢体24个月二期累积通畅率分别为90%和79%,临床显著改善的肢体比例分别为58%和73%,通畅率或临床结局均无统计学显著差异。

关键数值与推荐

  • 支架跨越腹股沟韧带置入健康静脉段者63条肢体(62%)。
  • 6例患者(7%)需要行静脉内膜切除术和瘘管创建。
  • 治疗前Villalta评分中位数为14分(范围5-33分)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: The aim was to assess two year outcomes with placement of the Vici Venous Stent® in patients with chronic iliofemoral venous occlusions (complete blockage). METHODS: This was a retrospective single centre study comprising patients treated with the Vici Venous Stent for venographically verified iliofemoral venous occlusion and post-thrombotic syndrome (Villalta score ≥ 5 points) at least 12 months after acute deep vein thrombosis. Venography and intravascular ultrasound were used peri-operatively; duplex ultrasound was used to assess stent patency during follow up. RESULTS: Eighty-eight patients (101 limbs) had stent placement between March 2014 and October 2016. Median pre-treatment Villalta score was 14 (range 5-33). Stenting extended across the inguinal ligament in 63 limbs (62%) in order to land in a healthy venous segment. Six patients (7%) required endophlebectomy and fistula creation. Median imaging follow up was 21 months (range 0-41 months). Primary, assisted primary and secondary patency rates at one year were 59%, 78%, and 87%, respectively, and two years 51%, 73%, and 82%, respectively. Forty-three limbs (43%) had re-intervention (lysis, venoplasty, and/or placement of stent) during follow up; median time to re-intervention was 32 days (range 0-520 days). At 24 months, 37 of 53 limbs (70%) with available Villalta assessment showed clinically significant improvement (>30% reduction of baseline score). Villalta scores at the 6, 12, and 24 month clinical follow up were significantly lower than before stenting (p < .001, all time points). In a subset analyses of limbs with stenting terminating above and below the inguinal ligament, secondary cumulative patency rates at 24 months were 90% and 79%, respectively; clinical outcome showed 58% vs. 73% of limbs with clinically significant improvement, respectively. There was no statistically significant difference in patency or clinical outcomes. CONCLUSION: The Vici Venous Stent is associated with a good secondary patency rate and durable and substantial symptomatic resolution in patients with chronic post-thrombotic occlusions, regardless of whether stents extended beneath the inguinal ligament.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Black S, Gwozdz A, Karunanithy N, et al. Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent®. Eur J Vasc Endovasc Surg. 2018. PMID: 30139572. doi:10.1016/j.ejvs.2018.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。